Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 53 of 5804
-
New lung cancer drug aims to match Keytruda's success
Disease control OngoingThe goal of this Phase 3 clinical trial is to compare efficacy and safety of CT-P51 and European Union (EU) approved Keytruda in combination with platinum pemetrexed chemotherapy in patients with previously untreated metastatic nsNSCLC.
Phase: PHASE3 • Sponsor: Celltrion • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Ancient herb, modern hope: ashwagandha compound tested to prevent deadly transplant complication
Disease control Recruiting nowWhat is acute Graft versus host disease (aGvHD)? GvHD is a complication that can occur after an allogeneic stem cell transplant resulting in damage to some organs. The death rate of GvHD patients is 15-40%. In GvHD, the donated peripheral blood stem cells or bone marrow view the …
Phase: PHASE1, PHASE2 • Sponsor: Tata Memorial Centre • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Two-Drug combo aims to wipe out childhood leukemia faster
Disease control Recruiting nowThis is a Phase II clinical trial testing the use of two antigen-directed therapies, inotuzumab and blinatumomab, as part of induction therapy for children and young adults with newly diagnosed B-cell precursor acute lymphoblastic leukemia and lymphoma. Primary Objective * To a…
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for high-risk MDS: phase 3 trial of lisaftoclax combo launches
Disease control Recruiting nowA global multicenter, randomized, double-blind, placebo-controlled, pivotal phase III study. To evaluate overall survival (OS) of Lisaftoclax (APG-2575) combined with azacitidine (AZA) vs. placebo combined with azacitidine in newly diagnosed patients with HR-MDS.
Phase: PHASE3 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for tough colon cancer: drug cocktail boosts surgery success
Disease control Recruiting nowNeoadjuvant immunotherapy has shown promising therapeutic effects in mismatch repair-deficient or microsatellite instability-high (dMMR/MSI-H) colorectal cancer (CRC). However, for patients with mismatch repair-proficient or microsatellite stable (pMMR/MSS) CRC, the efficacy of P…
Phase: PHASE3 • Sponsor: Jun Huang • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a 2-Month TB cure replace 6 months of pills for kids?
Disease control Recruiting nowWhile drug-susceptible tuberculosis (TB) disease in children currently requires four to six months of treatment, most children may be able to be cured with a shorter treatment of more powerful drugs. Shorter treatment may be easier for children to tolerate and finish as well as e…
Phase: PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
CRISPR therapy takes on rare swelling disorder
Disease control OngoingThis Phase 3 study aims to evaluate the efficacy and safety of NTLA-2002 compared to placebo in participants with HAE.
Phase: PHASE3 • Sponsor: Intellia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Personalized cell therapy takes on advanced melanoma in major trial
Disease control Recruiting nowThis clinical trial is a prospective, multicenter, open-label, randomized, actively controlled, parallel-group Phase 3 clinical trial to evaluate the efficacy, safety and tolerability of treatment with IMA203 administered at the recommended phase 2 dose versus investigator's choi…
Phase: PHASE3 • Sponsor: Immatics US, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a diabetes drug curb opioid addiction? a trial puts semaglutide to the test
Disease control Recruiting nowThe goal of this clinical trial is to learn if semaglutide can reduce illicit opioid use in adults in outpatient treatment for opioid use disorder, and who are receiving either buprenorphine or methadone maintenance treatment. The main question it aims to answer is: • Does semag…
Phase: PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New hope for kids with rapid-aging disease: drug combo tested
Disease control OngoingResearchers will compare treatment with progerinin plus lonafarnib vs lonafarnib alone to assess optimal dosing, safety, tolerability, and pharmacokinetics in patients with Hutchinson-Gilford Progeria Syndrome (HGPS). Subjects in the randomized study arms will continue to take th…
Phase: PHASE2 • Sponsor: PRG Science & Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New CAR-T therapy aims to tackle tough childhood leukemia
Disease control Recruiting nowTo evaluate the efficacy and safety of S1904 in patients with relapsed or refractory CD19+B-ALL.
Phase: PHASE2 • Sponsor: Hebei Senlang Biotechnology Inc., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
One-Time gene fix could ease PKU's strict diet burden
Disease control Recruiting nowThis is a Phase 1/2, open-label, multiple-center, dose escalation and cohort expansion study to evaluate the safety and efficacy of NGGT002 in adult subjects with classic Phenylketonuria (PKU). NGGT002 is an rAAV8 based vector carrying a functional copy of the human PAH gene. Pa…
Phase: PHASE1, PHASE2 • Sponsor: NGGT INC. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug GQ1005 takes on T-DM1 in advanced HER2-Positive breast cancer
Disease control Recruiting nowThis study is designed to compare efficacy and safety of GQ1005 versus T-DM1 in HER2-positive, unresectable and/or metastatic breast cancer patients previously treated with trastuzumab and taxane.
Phase: PHASE3 • Sponsor: GeneQuantum Healthcare (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Drug combo aims to halt lung scarring in scleroderma
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy on lung function after 24 weeks of rituximab + MMF combination comparatively to placebo + MMF combination in patients with SSc-ILD severe at the initial assessment or at high risk of progression.
Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Absorbable 3D-Printed splint could save kids with rare breathing disorder
Disease control Recruiting nowThe purpose of this study is to learn if a three-dimensional (3D) printed airway splint device made to hold open a collapsing airway is a safe and effective treatment of Tracheobronchomalacia (TBM) in children. The airway splint is bioresorbable, meaning the child's body will ab…
Phase: NA • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Rectal cancer breakthrough: could a new drug combo save your rectum?
Disease control Recruiting nowThis study hypothesizes that approximately 50% of rectal cancer patients can preserve their rectum using a watch-and-wait strategy if they achieve a complete or near-complete clinical response to total neoadjuvant therapy (TNT). The objective is to determine whether the complicat…
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for tiny lungs: simpler breathing treatment tested for premature babies in africa
Disease control Recruiting nowThe goal of this pragmatic clinical trial is to learn if the drug surfactant given by a less invasive technique works to treat respiratory distress in preterm infants in low- and middle-income African countries where invasive ventilators are unavailable. It will also learn about …
Phase: PHASE4 • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a Heart-Lung machine at the scene of a cardiac arrest double survival?
Disease control OngoingCHEER4TTE is a target trial emulation, designed to simulate a randomised controlled trial by utilising data from pre-existing data sources. The aim is to determine whether prehospital ECPR for refractory out-of-hospital cardiac arrest improves the rate of survival to hospital dis…
Sponsor: Australian and New Zealand Intensive Care Research Centre • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
AI eye scanner could prevent blindness in millions with diabetes
Diagnosis Recruiting nowIn this pivotal trial, we aim to perform a prospective study to find the efficacy of iPredict-DR, an artificial intelligence (AI) based software tool on early diagnosis of Diabetic Retinopathy (DR) in the primary care and endocrinology clinics. DR is one of the leading causes of …
Sponsor: iHealthScreen Inc • Aim: Diagnosis
Last updated Jun 26, 2026 12:53 UTC
-
Can poop pills beat superbugs? new trial aims to stop antibiotic resistance
Disease control Recruiting nowThe aim of this research experiment is to evaluate the effectiveness of fecal microbiota transplantation (FMT) preceded by antibiotic pre-treatment versus probiotic therapy and a standard-of-care equivalent diet designed to stimulate the growth of eubiotic gut microbiota (an acti…
Phase: NA • Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Jun 26, 2026 12:32 UTC